Familial thrombophilia is an oligogenetic disease: involvement of the prothrombin G20210A, PROC and PROS gene mutations.
Population-based case-control studies and cases previously published suggest that the prothrombin G20210A mutation is a weak risk factor for thrombosis, leading to clinical expression mainly in the presence of other risk factors. We report the results of plasma and genetic analyses performed in a 13-year-old symptomatic boy homozygous for the 20210A allele and in his family, which are in accordance with this suggestion. These analyses demonstrated the presence of several PROC (R-5W, R87H) and PROS (R60C, T103N) gene mutations in this family. These additional mutations have modulating effects on clinical expression of the G20210A mutation. The present family study illustrates the concept of 'mild' mutation and the hypothesis that familial thrombophilia is a multifactorial disease.
Boinot
C
C
Laboratoire d'Hématologie and Laboratoire de Génétique Cellulaire et Moléculaire, CHU La Miletrie, Poitiers, France.
Borgel
D
D
Kitzis
A
A
Guicheteau
M
M
Aiach
M
M
Alhenc-Gelas
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D005192:Family Health; D005260:Female; D006580:Genetic Carrier Screening; D006720:Homozygote; D006801:Humans; D015151:Immunoblotting; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010375:Pedigree; D011486:Protein C / Q000235:genetics* / Q000378:metabolism; D020151:Protein C Deficiency / Q000097:blood / Q000235:genetics; D017293:Protein S / Q000235:genetics* / Q000378:metabolism; D018455:Protein S Deficiency / Q000097:blood / Q000235:genetics; D011516:Prothrombin / Q000235:genetics*; D019851:Thrombophilia / Q000097:blood / Q000235:genetics*; D013927:Thrombosis / Q000453:epidemiology / Q000235:genetics
D011486:Protein C; D017293:Protein S; D011516:Prothrombin